Farms.com Home   News

Dutch family comes to Canada for its lifestyle and looks to buy dairy farm

TILLSONBURG — Kornelis Schaafsma sold off the family dairy farm in the Netherlands earlier this year. Now he’s searching for a replacement here in Ontario, and the pickings are slim.

There just aren’t very many dairy farms up for sale in the province, at any price. Nevermind that Schaafsma expects to pump the entire $5 million to $6 million he collected on the sale of his Dutch operation, plus take on substantial additional debt, in return for an Ontario farm with about half the production capacity of the one he left behind in Friesland.

He says he’s in the market for a 60- to 120-head milking operation — a family farm he and his wife Aafje can handle by themselves — with about 100 acres to support it. He estimates the cost of such an operation, including roughly 75 kg of milk quota, at between $7 million to $8 million in southwestern Ontario and perhaps $5.5 million in Eastern Ontario.

He previously milked between 140 and 150 cows at the farm where he grew up in Holland.

Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.